4.8 Article

Insomnia Disorder

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 373, Issue 15, Pages 1437-1444

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMcp1412740

Keywords

-

Funding

  1. Merck
  2. UCB Pharma
  3. XenoPort
  4. Flex Pharma
  5. Purdue Pharma
  6. Transcept Pharmaceuticals
  7. NeuroMetrix

Ask authors/readers for more resources

A 77-year-old overweight woman with hypertension and arthritis reports that she has had trouble sleeping for as long as I can remember. She has taken hypnotic medications nightly for almost 50 years; her medication was recently switched from lorazepam (1 mg), which had been successful, to trazodone (25 mg) by her primary care physician, who was concerned about her use of the former. She spends 9 hours in bed, from 11 p.m. to 8 a.m. She has only occasional difficulty falling asleep, but she awakens two to three times per night to urinate and lies in bed for over an hour at those times, just worrying. How should her case be managed?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available